Form 8-K - Current report:
SEC Accession No. 0001104659-24-112240
Filing Date
2024-10-29
Accepted
2024-10-29 16:15:25
Documents
13
Period of Report
2024-10-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2427003d1_8k.htm   iXBRL 8-K 41134
  Complete submission text file 0001104659-24-112240.txt   217835

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zura-20241023.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20241023_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20241023_pre.xml EX-101.PRE 22357
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2427003d1_8k_htm.xml XML 3804
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 241405906
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)